Mereo BioPharma Group plc SEC filings MREO
Mereo BioPharma Group plc has 439 filings in SEC EDGAR's recent list, going back to Dec 1, 2017. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 19, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Aug 19, 2026 | Aug 18, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2026 | May 14, 2026 |
| 8-K/A |
Amended current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Acquisition or sale of assets
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 9, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 9, 2026 | Apr 8, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2026 | Mar 26, 2026 |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Listing notice
|
Feb 17, 2026 | Feb 17, 2026 |
| S-8 | Employee stock plan registration | Feb 2, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 29, 2025 | Dec 29, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Other events
|
Jul 10, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 8, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 8, 2025 | May 13, 2025 |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2025 | Mar 26, 2025 |
| S-8 | Employee stock plan registration | Jan 23, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 12, 2025 |
| EFFECT | Filing | Dec 4, 2024 | — |
| 424B3 | Prospectus | Dec 4, 2024 | — |
| CORRESP | Letter to the SEC | Dec 3, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2024 | — |
| S-3 | Shelf registration | Nov 25, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, Results of operations
|
Nov 12, 2024 | Nov 8, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 14, 2024 | Jun 14, 2024 |
| 424B5 | Prospectus supplement | Jun 14, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 12, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2024 | May 23, 2024 |
| EFFECT | Filing | May 22, 2024 | — |
| CORRESP | Letter to the SEC | May 21, 2024 | — |
| UPLOAD | Letter from the SEC | May 20, 2024 | — |
| S-3 | Shelf registration | May 15, 2024 | — |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| ARS | Annual report to shareholders | Apr 24, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 24, 2024 | May 23, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 15, 2024 | Apr 15, 2024 |
| 10-K | Annual report | Mar 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2024 | Mar 27, 2024 |
| S-8 | Employee stock plan registration | Jan 23, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-A12B/A | Filing | Dec 18, 2023 | — |
| 6-K | Current report (foreign issuer) | Dec 18, 2023 | Dec 18, 2023 |
| 6-K | Current report (foreign issuer) | Nov 29, 2023 | Nov 29, 2023 |
| 6-K | Current report (foreign issuer) | Nov 16, 2023 | Nov 16, 2023 |
| 6-K | Current report (foreign issuer) | Oct 23, 2023 | Oct 23, 2023 |
| 6-K | Current report (foreign issuer) | Oct 17, 2023 | Oct 17, 2023 |
| 6-K | Current report (foreign issuer) | Sep 20, 2023 | Sep 20, 2023 |
| 6-K | Current report (foreign issuer) | Sep 7, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jul 6, 2023 | Jul 6, 2023 |
| 6-K | Current report (foreign issuer) | Jun 30, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jun 7, 2023 | Jun 7, 2023 |
| 6-K | Current report (foreign issuer) | Jun 5, 2023 | Jun 5, 2023 |
| 6-K | Current report (foreign issuer) | May 22, 2023 | May 22, 2023 |
| 6-K | Current report (foreign issuer) | May 8, 2023 | May 8, 2023 |
| 6-K | Current report (foreign issuer) | May 5, 2023 | May 5, 2023 |
| 6-K | Current report (foreign issuer) | Apr 27, 2023 | Apr 27, 2023 |
| 6-K | Current report (foreign issuer) | Apr 12, 2023 | Apr 12, 2023 |
| 20-F | Annual report (foreign issuer) | Mar 28, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 28, 2023 | Mar 28, 2023 |
| 6-K | Current report (foreign issuer) | Mar 21, 2023 | Mar 21, 2023 |
| S-8 | Employee stock plan registration | Jan 24, 2023 | — |
| 6-K | Current report (foreign issuer) | Nov 10, 2022 | Nov 10, 2022 |
| 6-K | Current report (foreign issuer) | Nov 10, 2022 | Nov 10, 2022 |
| 6-K | Current report (foreign issuer) | Nov 2, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 2, 2022 | Nov 2, 2022 |
| 6-K | Current report (foreign issuer) | Oct 28, 2022 | Oct 28, 2022 |
| 6-K | Current report (foreign issuer) | Oct 21, 2022 | Oct 21, 2022 |
| 6-K | Current report (foreign issuer) | Oct 18, 2022 | Oct 18, 2022 |
| 6-K | Current report (foreign issuer) | Oct 17, 2022 | Oct 17, 2022 |
| 6-K | Current report (foreign issuer) | Oct 4, 2022 | Oct 3, 2022 |
| 6-K | Current report (foreign issuer) | Sep 26, 2022 | Sep 26, 2022 |
| 6-K | Current report (foreign issuer) | Sep 12, 2022 | Sep 12, 2022 |
| 6-K | Current report (foreign issuer) | Aug 31, 2022 | Aug 31, 2022 |
| UPLOAD | Letter from the SEC | Aug 24, 2022 | — |
| 6-K | Current report (foreign issuer) | Aug 22, 2022 | Aug 22, 2022 |
| CORRESP | Letter to the SEC | Aug 19, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2022 | — |
| 6-K | Current report (foreign issuer) | Jul 5, 2022 | Jul 5, 2022 |
| CT ORDER | Filing | Jun 13, 2022 | — |
| 6-K | Current report (foreign issuer) | Jun 2, 2022 | Jun 2, 2022 |
| 6-K | Current report (foreign issuer) | May 26, 2022 | May 26, 2022 |
| 6-K | Current report (foreign issuer) | May 26, 2022 | May 26, 2022 |
| 6-K | Current report (foreign issuer) | May 25, 2022 | May 25, 2022 |
| 8-A12B/A | Filing | May 17, 2022 | — |
| 6-K | Current report (foreign issuer) | May 17, 2022 | May 17, 2022 |
| 6-K | Current report (foreign issuer) | May 17, 2022 | May 17, 2022 |
| 6-K | Current report (foreign issuer) | May 9, 2022 | May 9, 2022 |
| 6-K | Current report (foreign issuer) | May 9, 2022 | May 9, 2022 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Mar 31, 2022 | Mar 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 14, 2022 | Mar 14, 2022 |
| 6-K | Current report (foreign issuer) | Mar 1, 2022 | Mar 1, 2022 |
| S-8 | Employee stock plan registration | Jan 13, 2022 | — |
| 6-K | Current report (foreign issuer) | Dec 22, 2021 | Dec 22, 2021 |
| 6-K | Current report (foreign issuer) | Nov 30, 2021 | Nov 30, 2021 |
| 6-K | Current report (foreign issuer) | Nov 4, 2021 | Nov 4, 2021 |
| 6-K | Current report (foreign issuer) | Nov 2, 2021 | Jun 30, 2021 |
| 6-K | Current report (foreign issuer) | Oct 26, 2021 | Oct 26, 2021 |
| 6-K | Current report (foreign issuer) | Oct 26, 2021 | Oct 26, 2021 |
| 6-K | Current report (foreign issuer) | Oct 1, 2021 | Oct 1, 2021 |
| EFFECT | Filing | Sep 30, 2021 | — |
| CORRESP | Letter to the SEC | Sep 29, 2021 | — |
| F-3/A | Filing | Sep 27, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2021 | — |
| 6-K | Current report (foreign issuer) | Sep 20, 2021 | Sep 20, 2021 |
| CORRESP | Letter to the SEC | Sep 7, 2021 | — |
| F-3/A | Filing | Sep 7, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2021 | — |
| F-6EF | Filing | Aug 13, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 5, 2021 | — |
| 6-K | Current report (foreign issuer) | Jul 20, 2021 | Jul 20, 2021 |
| 6-K | Current report (foreign issuer) | Jun 2, 2021 | Jun 2, 2021 |
| 6-K | Current report (foreign issuer) | May 28, 2021 | May 28, 2021 |
| 6-K | Current report (foreign issuer) | Apr 30, 2021 | Apr 30, 2021 |
| 6-K | Current report (foreign issuer) | Apr 16, 2021 | Apr 16, 2021 |
| 6-K | Current report (foreign issuer) | Mar 31, 2021 | Mar 31, 2021 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2021 | Dec 31, 2020 |
| 6-K | Current report (foreign issuer) | Feb 12, 2021 | Feb 12, 2021 |
| 6-K | Current report (foreign issuer) | Feb 10, 2021 | Feb 10, 2021 |
| 424B5 | Prospectus supplement | Feb 10, 2021 | — |
| 424B5 | Prospectus supplement | Feb 9, 2021 | — |
| 6-K | Current report (foreign issuer) | Feb 1, 2021 | Feb 1, 2021 |
| S-8 | Employee stock plan registration | Jan 15, 2021 | — |
| 6-K | Current report (foreign issuer) | Jan 14, 2021 | Jan 14, 2021 |
| 6-K | Current report (foreign issuer) | Dec 17, 2020 | Dec 17, 2020 |
| 6-K | Current report (foreign issuer) | Dec 15, 2020 | Dec 15, 2020 |
| 6-K | Current report (foreign issuer) | Nov 16, 2020 | Nov 16, 2020 |
| 6-K | Current report (foreign issuer) | Nov 12, 2020 | Nov 12, 2020 |
| 424B5 | Prospectus supplement | Oct 23, 2020 | — |
| EFFECT | Filing | Oct 21, 2020 | — |
| CORRESP | Letter to the SEC | Oct 20, 2020 | — |
| 6-K | Current report (foreign issuer) | Oct 20, 2020 | Oct 20, 2020 |
| 6-K | Current report (foreign issuer) | Oct 19, 2020 | Oct 19, 2020 |
| 6-K | Current report (foreign issuer) | Oct 13, 2020 | Oct 13, 2020 |
| UPLOAD | Letter from the SEC | Oct 9, 2020 | — |
| 6-K | Current report (foreign issuer) | Oct 9, 2020 | Oct 9, 2020 |
| 6-K | Current report (foreign issuer) | Oct 7, 2020 | Oct 7, 2020 |
| F-3 | Shelf registration (foreign issuer) | Oct 6, 2020 | — |
| F-6EF | Filing | Oct 6, 2020 | — |
| 6-K | Current report (foreign issuer) | Oct 1, 2020 | Oct 1, 2020 |
| 6-K | Current report (foreign issuer) | Sep 29, 2020 | Jun 30, 2020 |
| 6-K | Current report (foreign issuer) | Sep 28, 2020 | Sep 28, 2020 |
| 6-K | Current report (foreign issuer) | Sep 28, 2020 | Sep 28, 2020 |
| 6-K | Current report (foreign issuer) | Sep 24, 2020 | Sep 24, 2020 |
| 6-K | Current report (foreign issuer) | Sep 4, 2020 | Sep 4, 2020 |
| 6-K | Current report (foreign issuer) | Aug 25, 2020 | Aug 25, 2020 |
| 6-K | Current report (foreign issuer) | Aug 3, 2020 | Aug 3, 2020 |
| EFFECT | Filing | Jul 10, 2020 | — |
| EFFECT | Filing | Jul 9, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2020 | — |
| CORRESP | Letter to the SEC | Jul 9, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 6, 2020 | — |
| POS AM | Filing | Jul 2, 2020 | — |
| 6-K | Current report (foreign issuer) | Jun 30, 2020 | Jun 30, 2020 |
| 6-K | Current report (foreign issuer) | Jun 16, 2020 | Jun 16, 2020 |
| 20-F | Annual report (foreign issuer) | Jun 15, 2020 | Dec 31, 2019 |
| D | Filing | Jun 12, 2020 | — |
| 6-K | Current report (foreign issuer) | Jun 9, 2020 | Jun 9, 2020 |
| 6-K | Current report (foreign issuer) | Jun 5, 2020 | Jun 4, 2020 |
| 6-K | Current report (foreign issuer) | May 27, 2020 | May 27, 2020 |
| 6-K | Current report (foreign issuer) | May 22, 2020 | May 22, 2020 |
| 6-K | Current report (foreign issuer) | Apr 28, 2020 | Apr 28, 2020 |
| 6-K | Current report (foreign issuer) | Mar 27, 2020 | Mar 27, 2020 |
| EFFECT | Filing | Mar 19, 2020 | — |
| CORRESP | Letter to the SEC | Mar 18, 2020 | — |
| F-1/A | Filing | Mar 12, 2020 | — |
| F-1/A | Filing | Mar 6, 2020 | — |
| CORRESP | Letter to the SEC | Mar 6, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 2, 2020 | — |
| 6-K | Current report (foreign issuer) | Feb 28, 2020 | Feb 28, 2020 |
| 6-K | Current report (foreign issuer) | Feb 21, 2020 | Feb 21, 2020 |
| 6-K | Current report (foreign issuer) | Feb 19, 2020 | Feb 19, 2020 |
| S-8 | Employee stock plan registration | Feb 18, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Feb 18, 2020 | — |
| 6-K | Current report (foreign issuer) | Feb 18, 2020 | Feb 18, 2020 |
| 6-K | Current report (foreign issuer) | Feb 12, 2020 | Feb 12, 2020 |
| 6-K | Current report (foreign issuer) | Feb 10, 2020 | Feb 10, 2020 |
| 6-K | Current report (foreign issuer) | Jan 14, 2020 | Jan 14, 2020 |
| 6-K | Current report (foreign issuer) | Jan 13, 2020 | Jan 13, 2020 |
| 6-K | Current report (foreign issuer) | Nov 22, 2019 | Nov 22, 2019 |
| 6-K | Current report (foreign issuer) | Oct 7, 2019 | Oct 7, 2019 |
| 6-K | Current report (foreign issuer) | Sep 17, 2019 | Sep 17, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MREO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- London
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1719714
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.